- Home
- LMND vs VKTX Comparison
LMND vs VKTX Comparison
Compare LMND & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LMND | VKTX |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LMND | VKTX |
|---|---|---|
| Price | $39.82 | $28.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | $56.33 | ★ $95.32 |
| AVG Volume (30 Days) | 1.2M | ★ 4.3M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.40 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $737,900,000.00 | N/A |
| Revenue This Year | $67.61 | N/A |
| Revenue Next Year | $34.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.15 | N/A |
| 52 Week Low | $39.11 | $23.82 |
| 52 Week High | $99.90 | $43.15 |
Technical Indicators
Market Signals| Indicator | LMND | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 53.41 |
| Support Level | N/A | $26.47 |
| Resistance Level | $47.31 | $34.00 |
| Average True Range (ATR) | 2.37 | 1.59 |
| MACD | -0.36 | 0.48 |
| Stochastic Oscillator | 9.32 | 100.00 |
Price Performance
Historical ComparisonAbout LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.